Skip to content

Welltower WELL United States — Percentage

Other geography segments

United Kingdom
32.3%+108%
Canada
9.2%+41.5%

Similar metrics at other companies

Personalis, Inc. logo
PSNLUS — Percentage Of Revenue
94%+6.0pp
Science Applications International Corporation logo
SAICUNITED STATES — Percentage of sales
24.5%0.0pp
Research Solutions logo
RSSSUS — Percentage Of Revenue
55.7%-1.3pp
GHC
GHCU.S. — Percentage of Revenue
78%0.0pp
Northrop Grumman logo
NOCUnited States — Sales percentage
86%-1.0pp
NCR Atleos logo
NATLUnited States — Percentage of revenues by geographic area
11.3%0.0pp

Other financials

Income statement

See full
Revenue$3.4B+38.3%
Gross profit$1.3B+35.0%
Net income$752.3M+192%
EPS (diluted)$0.61+35.6%

Balance sheet

See full
Cash & equivalents$4.7B+34.3%
Total debt$2.1B+59.5%
Total equity$43.8B+29.0%
Total assets$67.2B+26.1%

Cash flow

See full
Operating cash flow$670.0M+11.9%
CapEx$269.8M+12.3%
Free cash flow$400.2M+11.6%

Valuation

See full
Market cap$177.94B+71.9%
Enterprise value$175.29B+74.5%

Profitability

See full
Gross margin39.8%+0.6pp
Net margin12.4%-0.5pp
FCF margin15.9%-1.4pp

Returns & leverage

See full
Return on equity3.7%+0.2pp
Debt / equity0.0×

Where this comes from

Reported directly by Welltower in its filing.

Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.

The official record: Welltower’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Welltower's united states — percentage.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Welltower's united states — percentage?
Welltower (WELL) reported united states — percentage of 64.3% in Q1 2026.
How has Welltower's united states — percentage changed year-over-year?
Welltower's united states — percentage decreased by 17.6% year-over-year, from 78% to 64.3%.
What does united states — percentage mean?
This metric represents the proportion of the company's total consolidated revenue or asset base that is derived from operations within the United States. It is used to measure geographic concentration and the relative importance of the domestic market compared to international holdings. Investors use this to assess the company's exposure to U.S.-specific regulatory, economic, and healthcare reimbursement environments.